Search Page

1

Cite

Share

Mechanisms of anabolic therapies for osteoporosis.

Canalis E, Giustina A, Bilezikian JP. Canalis E, et al. N Engl J Med. 2007 Aug 30;357(9):905-16. doi: 10.1056/NEJMra067395. N Engl J Med. 2007. PMID: 17761594 Review. No abstract available.

Cite

Share

2

Cite

Share

New treatment modalities in osteoporosis.

Canalis E. Canalis E. Endocr Pract. 2010 Sep-Oct;16(5):855-63. doi: 10.4158/EP10048.RA. Endocr Pract. 2010. PMID: 20350910 Free PMC article. Review.

Cite

Share

3

Cite

Share

Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Canalis E, et al. Osteoporos Int. 2007 Oct;18(10):1319-28. doi: 10.1007/s00198-007-0394-0. Epub 2007 Jun 14. Osteoporos Int. 2007. PMID: 17566815 Review.

Cite

Share

4

Cite

Share

Growth factor control of bone mass.

Canalis E. Canalis E. J Cell Biochem. 2009 Nov 1;108(4):769-77. doi: 10.1002/jcb.22322. J Cell Biochem. 2009. PMID: 19718659 Free PMC article. Review.

Cite

Share

5

Cite

Share

Update in new anabolic therapies for osteoporosis.

Canalis E. Canalis E. J Clin Endocrinol Metab. 2010 Apr;95(4):1496-504. doi: 10.1210/jc.2009-2677. J Clin Endocrinol Metab. 2010. PMID: 20375217 Free PMC article. Review.

Cite

Share

6

Cite

Share

Growth hormone, insulin-like growth factors, and the skeleton.

Giustina A, Mazziotti G, Canalis E. Giustina A, et al. Endocr Rev. 2008 Aug;29(5):535-59. doi: 10.1210/er.2007-0036. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436706 Free PMC article. Review.

Cite

Share

7

Cite

Share

Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.

Zanotti S, Stadmeyer L, Smerdel-Ramoya A, Durant D, Canalis E. Zanotti S, et al. J Endocrinol. 2009 May;201(2):263-74. doi: 10.1677/JOE-08-0514. Epub 2009 Feb 13. J Endocrinol. 2009. PMID: 19218285 Free PMC article.

Cite

Share

8

Cite

Share

Connective tissue growth factor enhances osteoblastogenesis in vitro.

Smerdel-Ramoya A, Zanotti S, Deregowski V, Canalis E. Smerdel-Ramoya A, et al. J Biol Chem. 2008 Aug 15;283(33):22690-9. doi: 10.1074/jbc.M710140200. Epub 2008 Jun 25. J Biol Chem. 2008. PMID: 18583340 Free PMC article.

Cite

Share

9

Cite

Share

C/EBP homologous protein is necessary for normal osteoblastic function.

Pereira RC, Stadmeyer L, Marciniak SJ, Ron D, Canalis E. Pereira RC, et al. J Cell Biochem. 2006 Feb 15;97(3):633-40. doi: 10.1002/jcb.20660. J Cell Biochem. 2006. PMID: 16220546

Cite

Share

10

Cite

Share

CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.

Pereira RC, Stadmeyer LE, Smith DL, Rydziel S, Canalis E. Pereira RC, et al. Bone. 2007 Mar;40(3):619-26. doi: 10.1016/j.bone.2006.09.028. Epub 2006 Nov 7. Bone. 2007. PMID: 17095306 Free PMC article.

Cite

Share